Hubei Kailong Chemical Group Co., Ltd.
SZSE:002783.SZ
9.22 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,778.758 | 3,405.946 | 2,741.291 | 2,010.941 | 1,891.372 | 1,865.21 | 1,358.95 | 953.713 | 890.605 | 884.275 | 895.939 | 918.987 | 785.417 | 570.077 | 477.138 | 392.882 |
Cost of Revenue
| 2,748.087 | 2,591.486 | 2,114.087 | 1,456.172 | 1,199.156 | 1,234.947 | 855.281 | 555.682 | 554.394 | 524.491 | 533.863 | 583.465 | 473.305 | 311.051 | 239.612 | 260.811 |
Gross Profit
| 1,030.671 | 814.459 | 627.204 | 554.77 | 692.216 | 630.263 | 503.67 | 398.031 | 336.211 | 359.784 | 362.075 | 335.522 | 312.113 | 259.025 | 237.526 | 132.071 |
Gross Profit Ratio
| 0.273 | 0.239 | 0.229 | 0.276 | 0.366 | 0.338 | 0.371 | 0.417 | 0.378 | 0.407 | 0.404 | 0.365 | 0.397 | 0.454 | 0.498 | 0.336 |
Reseach & Development Expenses
| 80.709 | 66.936 | 45.486 | 29.973 | 50.859 | 40.032 | 41.444 | 30.08 | 26.469 | 24.107 | 29.561 | 16.743 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 162.083 | 65 | 67.339 | 49.217 | 44.958 | 39.65 | 38.454 | 22.203 | 15.077 | 16.528 | 16.699 | 15.205 | 66.497 | 63.01 | 59.344 | 34.351 |
Selling & Marketing Expenses
| 94.341 | 77.28 | 76.791 | 56.099 | 211.349 | 177.387 | 158.519 | 137.773 | 107.058 | 103.459 | 99.841 | 97.124 | 90.801 | 72.652 | 61.19 | 40.221 |
SG&A
| 256.424 | 142.28 | 144.131 | 105.316 | 256.307 | 217.037 | 196.973 | 159.976 | 122.136 | 119.986 | 116.54 | 112.329 | 157.298 | 135.662 | 120.534 | 74.572 |
Other Expenses
| -27.495 | 247.877 | 281.993 | 161.915 | 134.841 | -8.29 | 0.524 | 8.161 | 7.357 | 4.151 | 4.517 | 3.022 | -0.209 | 8.793 | 18.842 | 16.033 |
Operating Expenses
| 533.43 | 457.093 | 471.61 | 297.204 | 442.007 | 383.571 | 338.409 | 256.049 | 204.782 | 201.782 | 200.52 | 178.567 | 163.353 | 140.986 | 125.371 | 77.533 |
Operating Income
| 330.33 | 358.443 | 103.137 | 270.766 | 267.468 | 175.734 | 173.806 | 143.156 | 125.155 | 145.429 | 152.563 | 142.357 | 144.065 | 114.299 | 100.093 | 46.164 |
Operating Income Ratio
| 0.087 | 0.105 | 0.038 | 0.135 | 0.141 | 0.094 | 0.128 | 0.15 | 0.141 | 0.164 | 0.17 | 0.155 | 0.183 | 0.2 | 0.21 | 0.118 |
Total Other Income Expenses Net
| -194.406 | -169.557 | -603.635 | -152.053 | -114.451 | -79.248 | 9.069 | 9.015 | 0.885 | -8.651 | -4.492 | -12.474 | -4.904 | 5.053 | 6.781 | 7.659 |
Income Before Tax
| 302.835 | 188.887 | -500.498 | 118.713 | 153.017 | 167.444 | 174.331 | 150.996 | 132.314 | 149.351 | 157.063 | 144.481 | 143.856 | 123.092 | 118.935 | 62.197 |
Income Before Tax Ratio
| 0.08 | 0.055 | -0.183 | 0.059 | 0.081 | 0.09 | 0.128 | 0.158 | 0.149 | 0.169 | 0.175 | 0.157 | 0.183 | 0.216 | 0.249 | 0.158 |
Income Tax Expense
| 55.888 | 33.166 | -14.063 | 25.148 | 39.903 | 35.374 | 36.126 | 27.458 | 22.902 | 29.875 | 25.216 | 29.604 | 21.387 | 19.046 | 18.141 | 7.785 |
Net Income
| 175.351 | 133.332 | -486.435 | 93.565 | 113.114 | 81.764 | 115.013 | 108.78 | 97.594 | 107.153 | 121.612 | 105.347 | 106.005 | 94.034 | 95.303 | 52.156 |
Net Income Ratio
| 0.046 | 0.039 | -0.177 | 0.047 | 0.06 | 0.044 | 0.085 | 0.114 | 0.11 | 0.121 | 0.136 | 0.115 | 0.135 | 0.165 | 0.2 | 0.133 |
EPS
| 0.45 | 0.35 | -1.27 | 0.25 | 0.32 | 0.24 | 0.34 | 0.33 | 0.39 | 0.43 | 0.49 | 0.42 | 0.42 | 0.38 | 0.38 | 0.21 |
EPS Diluted
| 0.45 | 0.35 | -1.27 | 0.25 | 0.32 | 0.24 | 0.34 | 0.33 | 0.39 | 0.43 | 0.49 | 0.42 | 0.42 | 0.38 | 0.38 | 0.21 |
EBITDA
| 810.309 | 647.57 | 402.177 | 465.328 | 432.22 | 365.992 | 285.738 | 229.513 | 214.25 | 231.181 | 228.897 | 217.056 | 148.867 | 116.361 | 118.353 | 57.655 |
EBITDA Ratio
| 0.214 | 0.19 | 0.147 | 0.231 | 0.229 | 0.196 | 0.21 | 0.241 | 0.241 | 0.261 | 0.255 | 0.236 | 0.19 | 0.204 | 0.248 | 0.147 |